期刊文献+

联合免疫治疗肝门部胆管癌根治术后皮肤多发转移 被引量:2

原文传递
导出
摘要 患者女,17岁。因皮肤、巩膜黄染25d于1999年2月3日入院。入院体格检查:皮肤、巩膜黄染,余无特殊发现。腹部B超检查:肝内胆管扩张伴胆囊增大,肝外胆管起始段扩张。实验室检查:TBil 242.4μmol/L,DBil 155.9μmol/L,AFP及CEA在正常范围。术中探查:位于胆囊管开1:3处的胆总管有1个包块,于十二指肠上缘处切断胆总管,沿门静脉前方向上分离胆总管及肿瘤,离断肝动脉,然后将左右胆管连同包块及胆囊全部切除。
出处 《中华消化外科杂志》 CAS CSCD 2010年第4期316-317,共2页 Chinese Journal of Digestive Surgery
基金 全军十一五专项课题(082016)
  • 相关文献

参考文献7

二级参考文献27

  • 1Jun Sakata,Yoshio Shirai,Toshifumi Wakai,Tatsuya Nomura,Eiko Sakata,Katsuyoshi Hatakeyama.Catheter tract implantation metastases associated with percutaneous biliary drainage for extrahepatic cholangiocarcinoma[J].World Journal of Gastroenterology,2005,11(44):7024-7027. 被引量:32
  • 2刘颖斌,彭淑牖.胆肠吻合术后再次或多次手术的原因和处理[J].中国实用外科杂志,2006,26(3):165-167. 被引量:41
  • 3何芳,廖国庆,张光全.B超引导下应用PTCD治疗胆道梗阻23例临床分析[J].局解手术学杂志,2006,15(3):171-172. 被引量:6
  • 4Klatskin G.Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis.an unusual tumor with distinctive clinical and pathological features.Am J Med,1965,38:241-256.
  • 5Bismuth H,Nakache R,Diamond T.Management strategies in resection for hilar cholangiocarcinoma.Ann Surg,1992,215:31-38.
  • 6Clary B,Jarnigan W,Pitt H,et al.Hilar cholangiocarcinoma.J Gastrointest Surg,2004,8:298-302.
  • 7Nakagohri T,Asano T,Kinoshita H,et al.Aggressive surgical resection for Hilar-invasive and peripheral intrahepatic cholangiocarcinoma.World J Surg,2003,27:289-293.
  • 8Ogura Y,Kawarada Y,Surgical strategies for carcinoma of the hepatic duct confluence.Br J Surg,1998,85:20-24.
  • 9Sakaguchi S,Nakamura S.Surgery of the portal vein in resection of cancer of the hepatic hilus.Surgery,1986,99:344-349.
  • 10Nimura Y,Hayakawa N,Kamiya J,et al.Combined portal vein and liver resection for carcinoma of the biliary tract.Br J Surg,1991,28:727-731.

共引文献104

同被引文献30

  • 1陈漪,王志明,任正刚,乐凡,张博恒,夏景林,叶胜龙,汤钊猷.CA19-9对肝细胞癌和胆管细胞癌的诊断价值[J].中华肝脏病杂志,2006,14(4):299-300. 被引量:27
  • 2秦莉,王志华.CIK细胞的体外培养与细胞毒作用[J].医学分子生物学杂志,2007,4(1):82-85. 被引量:16
  • 3孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 4Poultsides GA, Zhu AX, ChotiMA, et al. Intrahepatic cholangiocareinoma. Surg Clin North Am, 2010,90(4): 817-837.
  • 5Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and in aging findings. A JR Am J Roentgeno,2003,181( 3): 819-827.
  • 6Kobayashi S, Nakanuma Y, Terada T, et al. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroentero, 1993,88(9): 1410-1415.
  • 7Hontscha C, Borck Y, Zhou H, et al. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC) [ J ]. J Cancer Res Clin Oncol, 2011,137 (2) : 305- 310.
  • 8孙燕,汤钊猷.UICC临床肿瘤学手册[M].8版.北京:人民卫生出版社,2006:425-501.
  • 9Hoheika A C, Morse M A, Osada T, et al. Depletion of hu- man regulatory T cells[J]. Methods Mol Biol, 2011,707:219- 231.
  • 10Kim Y J, Lim J, Kang J S, et al. Adoptive immunothe of human gastric cancer with ex vivo expanded T cells[ J]. Arch Pharm Res, 2010,33 ( 11 ) : 1789-1795.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部